Company Overview

Update
Founded:
May, 2007
Founders:
Tillman Gerngross, K. Dane Wittrup
Headquarters:
Lebanon, NH
Funding:
$39.70M
Categories:
Biotechnology

Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.

Description

Update

Adimab's integrated antibody discovery and optimization platform provides unprecedented speed from antigen to purified, full-length human IgGs. Adimab offers fundamental advantages by delivering diverse panels of therapeutically relevant antibodies that meet the most aggressive standards for affinity, epitope coverage, species cross-reactivity and expressability. Adimab enables its partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.

Current Team (9)

Update

Board Members and Advisors (5)

Update

Funding Rounds (9) - $39.70M

Update

Investors (5)

Update
  • E20f6b7c14728a7e460451c809e5238d

    Google Ventures

    Venture capital fund
  • 15f86da14352d2d2ee9ca9c7cb407a29

    Borealis Ventures

    Borealis Ventures partners closely with exceptional entrepreneurs from the earliest stages to..
  • B1ce9d2887c930e2d5d82b64a7eebcb9

    OrbiMed Advisors

    OrbiMed is ahealthcare-dedicated investment firm, with approximately $5 billion in assets under..
  • C4d98fd27f8fa447d8201247f6b3377f

    Polaris Partners

    Polaris Partners is a venture company investing in digital media, life sciences, and enterprise..
  • 833227dddcb31df78412232c4596d5ad

    SV Life Sciences

    Venture capital Firm

Offices/Locations (1)

Update
  • Office

    16 Cavendish Court

    Lebanon, NH 03766

    USA